Submitted by Anonymous (not verified) on 17 October 2025 - 13:30
Human medicines European public assessment report (EPAR): Tecartus, brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tecartus, brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 14, Status: Authorised